TRANSITIONAL CELL CARCINOMA RECURRENT

This adverse event was reported 58 times

These drugs are most commonly taken by patients reporting TRANSITIONAL CELL CARCINOMA RECURRENT:

# Drug Count
0 PEMBROLIZUMAB 17
1 CISPLATIN 14
2 ENFORTUMAB VEDOTIN 14
3 GEMCITABINE HYDROCHLORIDE 13
4 GEMCITABINE 11
5 CARBOPLATIN 7
6 NIVOLUMAB 6
7 PACLITAXEL 6
8 PACLITAXEL (AIBUMIN-BOUND) 6
9 LENALIDOMIDE 5
See all common drugs associated with TRANSITIONAL CELL CARCINOMA RECURRENT

TRANSITIONAL CELL CARCINOMA RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NADOFARAGENE FIRADENOVEC-VNCG 1 0.0019
1 ENFORTUMAB VEDOTIN 14 0.0018
2 BACILLUS CALMETTE-GUERIN 3 0.0017
3 MITOMYCIN 2 0.0005
4 LUSPATERCEPT 1 0.0004
5 HYDROCORTISONE SODIUM SUCCINATE 1 0.0003
6 GEMCITABINE HYDROCHLORIDE 13 0.0002
7 CISPLATIN 14 0.0002
8 PEMBROLIZUMAB 17 0.0002
9 DUTASTERIDE 1 0.0001
See all drugs enriched for association with TRANSITIONAL CELL CARCINOMA RECURRENT